Abstract
For quite some time the field of polycystic kidney disease has led a life at the fringe of kidney research, but with the cloning of the PKD1 and many other genes this situation has dramatically changed. Polycystic kidney disease often is a syndromic disease affecting a variety of organs in addition to the kidney. Most of the proteins involved in polycystic kidney disease have been localized to the primary cilium, an extension at the apical membrane of renal tubular epithelial cells, which may serve chemo- and mechanosensory functions. It is speculated that primary cilia and their associated proteins play a role in determining the proper tubular geometry.
Keywords: metanephric kidney, mutations, polycystin, glycoproteins, endoplasmic reticulum, nephrocystins, nphp gene, bardet-biedl proteins, cilia, chemosensors
Current Molecular Medicine
Title: New Developments in the Field of Cystic Kidney Diseases
Volume: 5 Issue: 5
Author(s): Ralph Witzgall
Affiliation:
Keywords: metanephric kidney, mutations, polycystin, glycoproteins, endoplasmic reticulum, nephrocystins, nphp gene, bardet-biedl proteins, cilia, chemosensors
Abstract: For quite some time the field of polycystic kidney disease has led a life at the fringe of kidney research, but with the cloning of the PKD1 and many other genes this situation has dramatically changed. Polycystic kidney disease often is a syndromic disease affecting a variety of organs in addition to the kidney. Most of the proteins involved in polycystic kidney disease have been localized to the primary cilium, an extension at the apical membrane of renal tubular epithelial cells, which may serve chemo- and mechanosensory functions. It is speculated that primary cilia and their associated proteins play a role in determining the proper tubular geometry.
Export Options
About this article
Cite this article as:
Witzgall Ralph, New Developments in the Field of Cystic Kidney Diseases, Current Molecular Medicine 2005; 5 (5) . https://dx.doi.org/10.2174/1566524054553496
DOI https://dx.doi.org/10.2174/1566524054553496 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics
Current Proteomics Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression
Current Medicinal Chemistry Subject Index To Volune 2
Current Cancer Therapy Reviews Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
Current Pharmaceutical Design Human Immunodeficiency Virus Interactions with CD8+ T Lymphocytes
Current HIV Research Immunosuppressive Properties of Mesenchymal Stem Cells: Advances and Applications
Current Molecular Medicine Treatment of Disorders Characterized by Reversible Airway Obstruction in Childhood: are Anti-cholinergic Agents the Answer?
Current Pharmaceutical Design Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Current Pharmaceutical Design Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics
Current Drug Targets Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology MicroRNAs in Genetic Disease: Rethinking the Dosage
Current Gene Therapy Copper Complexes of 8-Aminoquinoline and Uracils as Novel Aromatase Inhibitors
Letters in Drug Design & Discovery Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Current Drug Delivery Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Current Pharmaceutical Design Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders
Current Neuropharmacology Limitations of Current Antiretroviral Agents and Opportunities for Development
Current Pharmaceutical Design